Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01812174 · ClinicalTrials.gov registry record · NA
On-X Heart Valve - 17mm Aortic and 23mm Mitral
A NA study, sponsored by On-X Life Technologies.
- Terminated
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT01812174 is a NA study that was terminated before completion, run by On-X Life Technologies. The registered enrollment target is 20 participants.
The verdict
NCT01812174, a NA study, was terminated before completion, sponsored by On-X Life Technologies.
- TERMINATED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study examines the hemodynamic and hemolytic properties of two additional smaller size valves to the On-X line of valves already approved by FDA.
Interventions
- DEVICE 17mm aortic valve (On-X )
- DEVICE 23mm mitral valve (On-X)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2011-11-18 |
| Est. Completion | 2018-12-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01812174
The ClinicalTrials.gov registry entry for NCT01812174 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is On-X Life Technologies, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 17mm aortic valve (On-X ) is the first listed.
NCT01812174 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01812174 about?
NCT01812174 is a clinical study titled "On-X Heart Valve - 17mm Aortic and 23mm Mitral". This study examines the hemodynamic and hemolytic properties of two additional smaller size valves to the On-X line of valves already approved by FDA.
What is the current status of trial NCT01812174?
This trial is currently terminated. It is a NA study. The enrollment target is 20 participants. The study started on 2011-11-18. Estimated completion is 2018-12-07.
What interventions are being tested in trial NCT01812174?
The interventions under investigation include: 17mm aortic valve (On-X ) (DEVICE), 23mm mitral valve (On-X) (DEVICE).
Who is sponsoring clinical trial NCT01812174?
This trial is sponsored by On-X Life Technologies, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.